1. Home
  2. UMAC vs INFU Comparison

UMAC vs INFU Comparison

Compare UMAC & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UMAC
  • INFU
  • Stock Information
  • Founded
  • UMAC 2019
  • INFU 2005
  • Country
  • UMAC United States
  • INFU United States
  • Employees
  • UMAC N/A
  • INFU N/A
  • Industry
  • UMAC
  • INFU Medical/Dental Instruments
  • Sector
  • UMAC
  • INFU Health Care
  • Exchange
  • UMAC Nasdaq
  • INFU Nasdaq
  • Market Cap
  • UMAC 162.5M
  • INFU 189.2M
  • IPO Year
  • UMAC 2024
  • INFU N/A
  • Fundamental
  • Price
  • UMAC $12.82
  • INFU $8.91
  • Analyst Decision
  • UMAC Strong Buy
  • INFU
  • Analyst Count
  • UMAC 1
  • INFU 0
  • Target Price
  • UMAC $4.00
  • INFU N/A
  • AVG Volume (30 Days)
  • UMAC 11.0M
  • INFU 61.1K
  • Earning Date
  • UMAC 11-14-2024
  • INFU 11-07-2024
  • Dividend Yield
  • UMAC N/A
  • INFU N/A
  • EPS Growth
  • UMAC N/A
  • INFU 60.96
  • EPS
  • UMAC N/A
  • INFU 0.07
  • Revenue
  • UMAC $3,561,303.00
  • INFU $132,783,999.00
  • Revenue This Year
  • UMAC N/A
  • INFU $10.49
  • Revenue Next Year
  • UMAC $66.18
  • INFU $8.84
  • P/E Ratio
  • UMAC N/A
  • INFU $128.89
  • Revenue Growth
  • UMAC N/A
  • INFU 8.17
  • 52 Week Low
  • UMAC $0.98
  • INFU $5.74
  • 52 Week High
  • UMAC $23.62
  • INFU $10.99
  • Technical
  • Relative Strength Index (RSI)
  • UMAC 61.93
  • INFU 54.47
  • Support Level
  • UMAC $10.60
  • INFU $8.80
  • Resistance Level
  • UMAC $13.75
  • INFU $9.18
  • Average True Range (ATR)
  • UMAC 2.68
  • INFU 0.33
  • MACD
  • UMAC 0.05
  • INFU -0.09
  • Stochastic Oscillator
  • UMAC 30.50
  • INFU 22.69

About UMAC Unusual Machines Inc. Common Stock

Unusual Machines Inc is a development stage technology company.

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.

Share on Social Networks: